Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (211-220 of 329) with videos related to

Pageof 33
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patientsNicolas Girard, Sylvain Marchand-Adam, Jean-Marc Naccache, et al.
The European Respiratory Journal|September 19, 2015
Phenotyping chronic pulmonary aspergillosis by cluster analysisCendrine Godet, François Laurent, Guillaume Béraud, et al.
ERJ Open Research|April 26, 2018
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancerAdrien Costantini, Jennifer Corny, Vincent Fallet, et al.
Mabs|December 9, 2014
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsVirginie Hervé, Nathalie Rabbe, Laurent Guilleminault, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lungThibault Vieira, Martine Antoine, Anne-Marie Ruppert, et al.
Translational Lung Cancer Research|October 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinomaGary Birsen, Valérie Gounant, Nicolas Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)Balazs Halmos, Eng-Huat Tan, Ross A Soo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2010
Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survivalEmilie Pluquet, Jacques Cadranel, Anne Legendre, et al.
Journal of Clinical Microbiology|March 18, 2026
Non-<i>fumigatus Aspergillus</i>-associated pulmonary events: a diagnostic challengeCendrine Godet, Valentin Joste, Jean-Pierre Frat, et al.
International Journal of Cancer|November 20, 2025
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIVSophie Grabar, Paula Lakrout, Valérie Potard, et al.
Pageof 33

Showing results (211-220 of 329) with videos related to

Sort By:
Pageof 33
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patientsNicolas Girard, Sylvain Marchand-Adam, Jean-Marc Naccache, et al.
The European Respiratory Journal|September 19, 2015
Phenotyping chronic pulmonary aspergillosis by cluster analysisCendrine Godet, François Laurent, Guillaume Béraud, et al.
ERJ Open Research|April 26, 2018
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancerAdrien Costantini, Jennifer Corny, Vincent Fallet, et al.
Mabs|December 9, 2014
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsVirginie Hervé, Nathalie Rabbe, Laurent Guilleminault, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lungThibault Vieira, Martine Antoine, Anne-Marie Ruppert, et al.
Translational Lung Cancer Research|October 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinomaGary Birsen, Valérie Gounant, Nicolas Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)Balazs Halmos, Eng-Huat Tan, Ross A Soo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2010
Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survivalEmilie Pluquet, Jacques Cadranel, Anne Legendre, et al.
Journal of Clinical Microbiology|March 18, 2026
Non-<i>fumigatus Aspergillus</i>-associated pulmonary events: a diagnostic challengeCendrine Godet, Valentin Joste, Jean-Pierre Frat, et al.
International Journal of Cancer|November 20, 2025
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIVSophie Grabar, Paula Lakrout, Valérie Potard, et al.
Pageof 33